<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Patel, Vasant B.</style></author><author><style face="normal" font="default" size="100%">Robbins, Mark A.</style></author><author><style face="normal" font="default" size="100%">Topol, Eric J.</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">C-reactive protein: A ‘golden marker’ for inflammation and coronary artery disease</style></title><secondary-title><style face="normal" font="default" size="100%">Cleveland Clinic Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2001</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2001-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">521-534</style></pages><volume><style face="normal" font="default" size="100%">68</style></volume><issue><style face="normal" font="default" size="100%">6</style></issue><abstract><style  face="normal" font="default" size="100%">Numerous studies have shown that elevated levels of C-reactive protein (CRP) are associated with increased cardiovascular risk. We advocate greater use of CRP measurements in clinical practice to identify patients at high risk in a variety of situations.</style></abstract></record></records></xml>